Article

Heidelberg expands product portfolio; appoints new GM, COO

Heidelberg Engineering USA announces that it continues to expand itsproduct portfolio with exclusive distribution rights in the United Statesand Canada for the Accumap Objective Perimeter from Objectivision Pty. Ltd.,Sydney, Australia.

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
Related Content
(Image credit: AdobeStock/iQoncept)
March 26th 2025

Beyond mentoring: The power of sponsorship and advocacy in ophthalmology

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Character Biosciences secures $93 million series B financing round
March 26th 2025

Character Biosciences secures $93 million series B financing round

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Alcon agrees to purchase LENSAR
March 25th 2025

Alcon agrees to purchase LENSAR

Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint
March 24th 2025

Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint

© 2025 MJH Life Sciences

All rights reserved.